Novartis India Limited (BOM:500672)

Market Cap	32.63B +22.2%
Revenue (ttm)	3.54B -0.5%
Net Income	931.80M -7.7%
EPS	37.74 -7.6%
Shares Out	24.69M
PE Ratio	35.01
Forward PE	n/a
Dividend	25.00 (1.88%)
Ex-Dividend Date	Jul 23, 2025

Volume	2,906
Open	1,306.75
Previous Close	1,295.10
Day's Range	1,306.75 - 1,329.90
52-Week Range	750.00 - 1,588.40
Beta	0.24
Analysts	Hold
Price Target	745.00 (-43.62%)
Earnings Date	Jul 29, 2026

About Novartis India

Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neuroscience products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited operates as a subsidiary of Novartis AG.

• Industry: Pharmaceutical Preparations
• Founded: 1947
• Employees: 56
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500672

Financial Performance

In fiscal year 2026, Novartis India's revenue was 3.54 billion, a decrease of -0.54% compared to the previous year's 3.56 billion. Earnings were 931.80 million, a decrease of -7.65%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 17, 2026

Data Sources Report a data error